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ABSTRACT 
 Cannabinoids are compounds that are naturally present in Cannabis sativa 
L., which interact with cannabinoid receptors in the nervous system, known as 
CB1 and CB2 receptors.  The most abundant and well-known cannabinoid that 
can be isolated from cannabis is 9-tetrahydrocannabinol (THC).  The structure of 
this compound specifically allows interaction with the CB1 and CB2 receptors, 
known as cannabimimetic activity.  Other compounds have since been produced, 
inspired by THC, which have been designed to elicit similar pharmacological 
responses, and therefore are beneficial as analgesics.  These compounds are 
known as synthetic cannabinoids. 
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 Synthetic cannabinoids, while potentially useful as therapeutic treatments 
for pain, are currently also popular as recreational drugs.  Herbal products that 
contain synthetic cannabinoids are sold as “legal highs,” as few of these 
compounds are illegal according to the Controlled Drugs and Substances Act.  
These products are prepared by combining synthetic cannabinoids and plant 
material, and are smoked similar to marijuana.  As the legality of many synthetic 
cannabinoids is quickly decreasing, as evidenced by the March 2011 emergency 
scheduling of five such compounds, it is becoming increasingly likely that these 
products will soon become popular exhibits to be submitted to controlled 
substances laboratories for testing.  If a previously smoked product is submitted, 
there could potentially be effects due to the burning, the presence of the plant or 
paper substrate, and other synthetic cannabinoids that could directly diminish 
the facility of analysis.  The aim of this thesis was to investigate these effects 
using four synthetic cannabinoids (AM-2201, JWH-015, HU-211, and RCS-4) and 
four substrates (tobacco, rolling paper, mint, and rosemary). 
 Results demonstrated diminished peak areas, which are likely due to the 
introduction of these variables, which include burning the drug of abuse, and 
spiking the drug of abuse onto various matrices.  The trend of lower peak areas 
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further suggests that burning, the presence of plant material, and other 
cannabinoids potentially all compromise the facility of analyzing synthetic 
cannabinoid products.   The act of burning one synthetic cannabinoid in 
particular, AM-2201, appeared to greatly decrease the capability to detect the 
analyte, as did the application of AM-2201 to various substrates.  Furthermore, 
the ability to detect AM-2201 appeared to vary greatly between results obtained 
from analyzing samples applied to different substrates.  Analysis of cannabinoid 
mixtures demonstrated that GC/MS analysis of different cannabinoids gave 
various peak areas although the concentrations remained consistent.  Peak area 
ratios of cannabinoid mixtures that were extracted from substrates were found to 
not differ significantly between the specific substrates studied.  This research 
supports that all of these variables should therefore be considered in regards to 
analysis of herbal products containing synthetic cannabinoids. 
  
viii 
 
Table of Contents 
Title Page                    i 
Reader’s Approval Page                 ii 
Dedicatory Page                 iii 
Acknowledgements                 iv 
Abstract                   v 
Table of Contents               viii 
List of Tables                  xi 
List of Figures                xii 
List of Abbreviations              xiv 
I. Introduction:                   1 
1. Cannabis and Cannabinoids                 1 
1.1. Popularity of Cannabis products               1 
1.2. Analysis of Cannabis and Components              2 
2. Development of Synthetic Cannabinoids               4 
 2.1 Use and Observed Social Trends of Synthetic Cannabinoids           8 
 2.2 Current Research of Synthetic Cannabinoids           12 
3. Objective                  14 
ix 
 
II. Materials and Methods                16 
1. Synthetic Cannabinoids                16 
2. Substrates                  17 
3. GC/MS Conditions                 18 
III. Experimental Design                19 
1. Optimization Studies                19 
 1.1 Optimizing a Burning Procedure for Synthetic Cannabinoid Analysis 
                   19 
 1.2 GC/MS Method Optimization              21 
  1.2.1. Selective Ion Monitoring (SIM) Methodology          22 
2. AM-2201 Standard Analysis               24 
 2.1 Unburned “Neat” AM-2201 Standard Analysis           24 
2.2. Burned AM-2201 Standard Analysis             25 
2.2.1 Burning of Smaller AM-2201 Concentrations          26 
3. Analysis of AM-2201-Spiked Substrates             27 
4. Analysis of AM-2201 Mixtures with Other Synthetic Cannabinoids         28 
5. Analysis of Substrates Spiked with Various Synthetic Cannabinoids         29 
IV. Results and Discussion                29 
x 
 
1. Unburned “Neat” AM-2201 Analysis              29 
2. Burned AM-2201 Analysis               31 
3. Effect of Burning on AM-2201 Peak Area             34 
4. AM-2201 Unburned Matrix Samples              36 
5. AM-2201 Burned Spiked Matrix Samples             38 
6. Cannabinoid Mixture Analysis               41 
IV. Conclusions                 46 
V. Discussion and Future Directions              47 
VI. References                 53 
VII. Curriculum Vitae                59 
  
xi 
 
List of Tables 
1. Parameters of BAS.m Method              21 
 
2. Parameters of AM2201SIMHM Method             21 
  
xii 
 
List of Figures 
1. Structure of 9-tetrahydrocannabinol (THC)              3 
 
2. Structures of CP 55,940 (left) and CP 47,947 (right)             5 
 
3. Structures of JWH-007 (left) and JWH-015 (right)             7 
 
4. Structures of synthetic cannabinoids that were categorized as          11 
Schedule I in March 2011 due to DEA emergency ban: a)  
JWH-018, b) JWH-073, c) JWH-200, d) CP-47,497,  
and e) Cannabicyclohexanol                
 
5. Structures of synthetic cannabinoids investigated: a) AM-2201,         17 
b) JWH-015, c) HU-211, and RCS-4 respectively            
 
6. Structures of a) caffeine and b) procaine             20 
 
7. Mass spectra of AM-2201 (a), JWH-015 (b), HU-211 (c), and RCS-4 (d)     22 
from the SWGDRUG database 
 
8. Detection of AM-2201 (Unburned) with Varied Concentration         30 
 
9. Detection of AM-2201 (Burned) with Varied Concentration          32 
 
10. Percent Recovery of AM-2201 from Spiked Substrate Samples          36 
(Unburned).          
 
11. AM-2201 SIM data for a) unburned, b) burned (after spiking),         39 
and c) burned (before spiking) tobacco. 
 
12. Peak Areas of Various Synthetic Cannabinoid Mixtures (Unburned)        42 
 
13. Peak Areas of HU-211 (Unburned)             43 
 
xiii 
 
14. Synthetic Cannabinoid Mixture Extractions from Various Substrates       45 
 
  
xiv 
 
List of Abbreviations 
AAPCC   American Association of Poison Control Center 
AM    Alexandros Makriyannis 
AM-2201   1-(5-fluoropentyl)-3-(1-naphthoyl) indole 
CBD    Cannabidiol 
CBN    Cannabinol 
CNS    Central Nervous System 
DEA    Drug Enforcement Administration 
FTIR    Fourier Transform Infrared Spectroscopy 
GC    Gas Chromatography 
GC/MS   Gas Chromatography/Mass Spectrometry 
HU    Hebrew University 
HU-210 3-(1,1'-dimethylheptyl)-6aR,7,10,10aR-tetrahydro-1-
hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-
methanol 
 
HU-211 3-(1,1-dimethylheptyl)-6aS,7,10,10aS-tetrahydro-1-
hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-
methanol 
 
JWH John W. Huffman 
xv 
 
JWH-015 (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl 
methanone 
 
JWH-018   (1-pentyl-1H-indol-3-yl)-1-naphthalenyl methanone 
LC    Liquid Chromatography 
LC/MS   Liquid Chromatography/Mass Spectrometry 
LLE    Liquid-Liquid Extraction 
m/z    Mass-to-Charge 
MDMA   3,4-methylenedioxy-N-methamphetamine 
mL    Milliliter 
NCC    Non-classical Cannabinoids 
PNS    Peripheral Nervous System 
RCS-4 (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl) 
methanone 
 
SIM    Selective Ion Monitoring 
SWGDRUG Scientific Working Group for the Analysis of Seized 
Drugs 
 
THC    9-tetrahydrocannabinol 
TLC    Thin-Layer Chromatography 
ug    Microgram 
1 
 
I. Introduction: 
1. Cannabis and Cannabinoids 
1.1 Popularity of Cannabis products 
 Narcotic agents have been abused throughout history, and the number of 
drugs that are commonly abused is consistently increasing.  The constant 
demand for new drugs of abuse leads to the development of new products, 
which are frequently regulated by the Drug Enforcement Administration (DEA).  
For example, 3,4-methylenedioxy-N-methamphetamine (MDMA) was developed 
during the 1980s era, but became the most popular during the 1990s, and was not 
classified as Schedule I on the Controlled Drugs and Substances Act until 2003.  
By 2003, other products had emerged on the market, which caused a decrease in 
the relative popularity of MDMA.1  The trend of MDMA popularity, therefore, 
followed a pattern that is often observed with many drugs of abuse: 
development, followed by increased popularity, subsequent regulation, and 
eventually a decrease in popularity compared to other drugs.  There are, 
however, particular controlled substances that remain prevalent in commercial 
markets in relation to both demand and supply.  Cannabis products and 9-
tetrahydrocannabinol (THC) products remain the most ubiquitous and the most 
frequently encountered substances in the United States.  In 2010, approximately 
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587,399 samples of the 1,713,360 drug exhibits that were submitted to forensic 
laboratories for analysis (approximately 34%) were determined to be cannabis or 
THC products.2 
1.2 Analysis of Cannabis and Components 
Cannabis submissions typically consist of plants (Cannabis sativa L. and 
related members of Cannabinaceae family) and resins or oils that are extracted 
from plant material.3  Cannabis sativa L. (cannabis), or marijuana samples can be 
presumptively identified in forensic laboratories by the characteristic cystolithic 
hairs and a positive Duquenois Levine test, while a conclusive identity of 
cannabis relies on the presence of specific naturally occurring compounds known 
as cannabinoids. 
Cannabinoids are defined as the C21 compounds contained within 
cannabis.3.  The most abundant cannabinoid present in cannabis was determined 
to be 9-tetrahydrocannabinol (THC), which was isolated in 19644.  Thus, the 
chemical definition of cannabinoids expanded to specifically encompass THC 
and respective analogues of THC.3  This definition can be further expanded to 
include unique pharmacological actions, referred to as cannabimimetic activity5.  
Cannabimimetic activity specifically describes the activation of certain receptors 
known as CB1 and CB2 receptors5.  CB1 receptors are present in the central 
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nervous system (CNS) and CB2 receptors are present in the peripheral nervous 
system (PNS).5  Although other cannabinoids present in cannabis may elicit 
cannabimimetic activity, the overall cannabimimetic activity of cannabis is 
defined by that of THC in particular.  In essence, the cannabimimetic activity 
exhibited by cannabis is determined exclusively by that of THC.  A possible 
reason for the unique mechanism of THC-related cannabimimetic activity is 
likely due to its structure.  The cannabimimetic activity associated with THC has 
been previously connected with three structural regions on the THC molecule 
(Figure 1) that specifically activate the CB1 receptor.  These pertinent groups 
include a characteristic cyclohexene ring, a hydroxyl functional group, and a 
carbon chain. 
O
CH3
OH
H
CH3
H
CH3 CH3
 
Figure 1. Structure of 9-tetrahydrocannabinol (THC) 
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In compounds that are structurally similar to THC, the amount of CB1 activity 
has been directly correlated to the length of the carbon chain bonded to the 
phenol.6  Although the structures of other natural cannabinoids present in 
cannabis, such as cannabidiol (CBD) and cannabinol (CBN), also feature these 
groups, the cannabimimetic activity displayed by cannabis is primarily 
attributed to THC.  Due to a lower affinity for the CB1 and CB2 receptors 
compared to THC,41 the activity of CBD is instead categorized by the different 
pharmacological responses observed from  other receptors that are not linked to 
the psychotropic effects of cannabis.7   
2. Development of Synthetic Cannabinoids 
 Activation of the cannabinoid receptors has been connected to the 
alleviation of inflammation and pain, which has caused CB1 and CB2 agonists to 
be subjects of high interest for researching possible analgesics.8  As THC is a 
well-known agonist of both CB1 and CB2 receptors, compounds began to be 
developed that were structurally similar to THC while maintaining unique 
structural properties; these were then identified as synthetic cannabinoids.  
Synthetic cannabinoids began to be developed as potential therapeutic agents 
based on similar cannabimimetic activities to THC, therefore presenting the 
potential for use as analgesic treatments.5  Pfizer pioneered this effort by 
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producing various compounds, known as non-classical cannabinoids (NCC’s) in 
attempt to discover drugs that would mimic the sedative and analgesic effects of 
cannabis without the damaging adverse effects.  One of the more notable NCC’s 
developed by Pfizer was CP 55,940.  Indeed, CP 55,940 was particularly relevant 
to the study of synthetic cannabinoids as the associated research led to the 
discovery of the CB1 and CB2 receptors.9  The structure of CP 55,940 (Figure 2) 
features similar groups to THC, which subsequently causes its cannabimimetic 
activity to be high.  The cannabimimetic activity of CP 55,940 is increased relative 
to THC due to the presence of unique functional groups.  Consequently, groups 
such as longer carbon chains also cause the potency of CP 55,940 to be higher 
than that of THC.  Specifically, the hydroxypropyl chain increases the 
cannabimimetic activity, relative to other Pfizer-produced CP compounds like 
CP 47,947, by a factor of 20.  The potency of CP 55,940 is therefore increased to be 
approximately 100 times higher than THC.9 
 
 
 
 
Figure 2. Structures of CP 55,940 (left) and CP 47,947 (right) 
OH
OH
OH
CH3
CH3
CH3
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OH
CH3
CH3
CH3
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Many research groups have continued the work of Pfizer, striving to discover 
and understand the pharmacological properties, and potential benefits, of 
synthetic cannabinoids.  Consequently, a high number of new synthetic 
cannabinoids have been developed.  The newly developed compounds all exhibit 
different structural characteristics, which results in varying levels of 
cannabimimetic activity. 
 An example of the more prominent research groups currently working on 
projects related to synthetic cannabinoids includes the John W. Huffman group, 
who has developed hundreds of synthetic cannabinoid compounds known as 
JWH cannabinoids.10  The aim of many of Huffman’s studies is to create 
simplified compounds that elicit typical cannabinoid responses.  The group 
therefore focuses on certain structural characteristics that can be altered and the 
changes in cannabimimetic activity that those changes incur.  Using the 
conclusions made by the Winthrop group (responsible for the WIN class of 
synthetic cannabinoids), namely that indole derivatives also demonstrate 
evidence of binding to cannabinoid receptors, the Huffman group strives to 
determine key aspects of structures that could either amplify or diminish 
cannabimimetic activity at either the CB1 or CB2 receptors.  One of their more 
relevant findings was the discovery that aminoalkyl groups bonded to indole 
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nitrogens, believed by the Winthrop group to be necessary for cannabimimetic 
activity, could be substituted by simpler alkyl groups.  Additionally, by 
manipulating the number of carbons present in this alkyl chain, the relative 
affinities of the resulting compounds can be controlled, as seen with the pentyl-
containing JWH-007 (which demonstrates high affinity for CB1 receptors and 
lower affinity for CB2 receptors) and the propyl-containing JWH-015 (which 
demonstrates low affinity for CB1 receptors and higher affinity for CB2 
receptors).40  The structures of JWH-007 and JWH-015 are displayed in Figure 3. 
  
 
 
 
 
Figure 3.  Structures of JWH-007 (left) and JWH-015 (right) 
Further work in the field of synthetic cannabinoids and how differences in 
structure can lead to differences in cannabimimetic activity has been explored by 
the research groups at The Hebrew University in Jerusalem, where the HU class 
of synthetic cannabinoids has been developed.11  The Mechoulam group 
synthesized HU-210 and its enantiomer, HU-211, and observed that while HU-
N
O
CH3
CH3
N
O
CH3
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210 appeared to show high cannabimimetic activity (approximately 100 times 
higher than THC), the other was effectively inert to cannabinoid receptors and 
was considered inactive (HU-211).12 
 Another significant aspect to the growing field of synthetic cannabinoid 
research is the investigation of and selectively activating one cannabinoid 
receptor over another.  This area of research is one pursued by the Alexandros 
Makriyannis group.  The classes of compounds currently being developed by 
this group, known as AM cannabinoids, consist of those specifically designed to 
activate the CB2 receptor in attempt to alleviate neuropathic pain.  These 
compounds, however, demonstrate no interaction with the CB1 receptor.13   
2.1 Use and Observed Social Trends of Synthetic Cannabinoids 
 Despite abundant research focused on the development of synthetic 
cannabinoids for use in pharmaceuticals, the compounds are commonly used as 
new drugs of abuse.  Cannabis products continue to be commonly used, but 
recent popular demand appears to have shifted to include synthetic 
cannabinoids.  Products that contain synthetic cannabinoids appear to be the 
illicit substances of choice, especially among the youth, and the market has 
responded accordingly as evidenced by the release of highly variable and 
available commercial products that have been sprayed or spiked with synthetic 
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cannabinoids.14  The most famous of these products include the popular “K2” 
and “spice” mixtures15  though other examples such as “Hayze Hurricane”, 
“Charge”, and “Hayze trainwreck” are also sold.16  These herbal products 
became available in 2006, and have since been sold as “legal highs.”17 
The increased popularity of synthetic cannabinoid products due to their 
current legality and presumed benign nature is concerning because of the 
resulting health problems related to their use.18  Symptoms that have been 
reported to be correlated to synthetic cannabinoid use include tachycardia, 
hypertension, chest pain, heart palpitations, hallucinations, racing thoughts, and 
seizures.19  In addition to the reports of these symptoms, evidence of potential 
harm due to synthetic cannabinoid use has also been recently explored and 
presented.  For example, the number of calls to the American Association of 
Poison Control Center (AAPCC) for cases connected to K2 smoking from 2009 to 
2010 increased from 53 to more than 2500.16 
In response to the reports of increasing abuse of herbal products, the DEA 
declared five commonly encountered synthetic cannabinoids as Schedule I on the 
Controlled Drugs and Substances Act in March 2011.20  The scheduling of the five 
most commonly encountered cannabinoids also aimed to deter the abuse of 
cannabinoid drugs that were believed to be responsible for serious medical 
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conditions. These compounds included (1-pentyl-1H-indol-3-yl)-1-naphthalenyl 
methanone (JWH-018), (1-butyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-
073), [1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-1-naphthalenyl methanone 
(JWH-200), 2-[(1R,3S)-3-hydroxycyclohexyl]- 5-(2,methyloctan-2yl)phenol (CP-
47,497), and 2-[(1R,3S)-3-hydroxycyclohexyl]- 5-(2-methylnonan-2-yl) phenol 
(cannabicyclohexanol).  The structures of these compounds are shown in Figure 
4.  
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    a)                                                                                      b)                                        
 
 
 
 
    c)                                                                                      d)                                        
 
 
 
 
    e) 
Figure 4. Structures of synthetic cannabinoids that were categorized as Schedule I in March 2011 
due to DEA emergency ban: a) JWH-018, b) JWH-073, c) JWH-200, d) CP-47,497, and e) 
Cannabicyclohexanol. 
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2.2 Current Research of Synthetic Cannabinoids 
 The increasing demand for synthetic cannabinoids and herbal incense 
products has directly influenced the research performed, which focuses on the 
components in specific herbal incense products.  Consequently, a more detailed 
understanding of the relative popularity of the different synthetic cannabinoids 
has been obtained.7,17,19,21,22,23,25  Similar research has furthermore exposed the 
global phenomenon of synthetic cannabinoid distribution, as the products are 
sold on an international scale through the utilization of the internet.29,31,34,35  
Another important benefit of synthetic cannabinoid research is the creation of 
databases and spectral libraries for synthetic cannabinoids.  Both the extensive 
study of various products, and the continuous discovery of new synthetic 
cannabinoids, can lead to valuable information.  Specifically, this consists of 
more detailed knowledge of chemical properties of synthetic cannabinoids that 
are encountered, and more knowledge in relation to the common synthetic 
cannabinoids observed to be in individual herbal products, all of which could 
contribute to the formation of databases.  Commercial products could be 
organized based on the synthetic cannabinoids they contain, and specific 
synthetic cannabinoids could potentially be targeted for analysis if knowledge of 
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a given brand of herbal product can give insight into which specific cannabinoids 
are commonly present in that brand.  
Similarly, the range of methods used to analyze synthetic cannabinoids is 
also an area of increasing interest for research.  Toxicology studies that focus on 
synthetic cannabinoid extraction and analysis feature the utilization of solid 
phase extraction and GC/MS to analyze cannabinoids contained in plasma.26  The 
synthetic cannabinoid targeted by the Batista group was ajulemic acid (AJA), a 
non-psychoactive synthetic cannabinoid derived from 11-nor-9-
tetrahydrocannabinol-9-carboxylic acid (THC-COOH), a metabolite of THC.  For 
this study, GC/MS was successfully used to determine concentrations of AJA as 
low as 10ng/mL.  GC/MS has also been expanded to include two-dimensional gas 
chromatography systems to analyze synthetic cannabinoids in oral fluid.7  Liquid 
chromatography methods are also being developed by groups such as the 
Auwarter group, who is working toward optimizing a procedure of using liquid-
liquid extraction (LLE) to extract synthetic cannabinoids present in serum, 
followed by using a liquid chromatography (LC) system in tandem with mass 
spectrometry.29 
While research is currently being conducted in order to improve the 
detection of synthetic cannabinoids, there are also studies aimed to associate 
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synthetic cannabinoid use with observable medical symptoms.  The investigation 
of various conditions that are reportedly connected with synthetic cannabinoid 
use leads to generation of social data about the popularity of synthetic 
cannabinoids.  Most notably, the trend of synthetic cannabinoid use among 
teenagers has been intensely studied in attempt to further understand the 
relative popularities of the various synthetic cannabinoids14,15,16 and also to glean 
the specific symptoms that can be attributed to synthetic cannabinoid use.18  
Common symptoms that were observed included both physical and 
psychoactive effects, including palpitations, tremors, changes in appetite, and 
blackouts, as well as feelings of euphoria, anxiety, changes in perception, and 
irritability. 
3. Objective 
One difference between synthetic cannabinoids and other products that 
are similarly abused is their preparation.  Exhibits containing synthetic 
cannabinoids are likely to be marketed in ways that are similar to other 
psychotropic plants, such as marijuana or salvia divinorum.  However, synthetic 
cannabinoids are manufactured and then applied to plant material; they do not 
occur naturally within the matrices in which they are commonly found.  Thus 
variables exist that could affect the analysis of synthetic cannabinoids that are 
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extracted from a matrix, which may not be considered when analyzing other 
plant-based drugs of abuse in which the drugs are naturally-occurring.  For 
example, little appears to be understood about the effects of burning on synthetic 
cannabinoid detection.  For forensic purposes, such a variable is useful as some 
exhibits that are submitted for analysis to controlled substances laboratories may 
already have been used, or smoked.  Plant material samples suspected to be 
marijuana are frequently submitted to laboratories for analysis in the form of 
cigarettes that have already been smoked.  When a burned marijuana cigarette, 
known colloquially as a “roach”, is analyzed for the presence of cannabinoids, 
results can sometimes differ from those obtained from unburned material.  These 
differences are evident in presumptive tests, such as the Duquenois-Levine test, 
and also in chromatographic tests, including thin layer chromatography (TLC).  
While the natural cannabinoids in marijuana can be detected after having been 
burned, whether or not the same effect would be observed in synthetic 
cannabinoid products is not known.  Additionally, components within the matrix 
of the herbal products, such as botanical interferants, or other illicit substances 
present at different concentrations, could potentially affect the detection and 
analysis of the cannabinoids.  It is the objective of this thesis, therefore, to 
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determine any differences, using a semi-quantitative technique, between peak 
areas of synthetic cannabinoids in solution and within a matrix.   
II. Materials and Methods 
1. Synthetic Cannabinoids 
 This study primarily focused on one target analyte, 1-(5-fluoropentyl)-3-
(1-naphthoyl) indole (AM-2201).  Additional cannabinoids were also used, 
including (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl methanone (JWH-
015), 3-(1,1-dimethylheptyl)-6aS,7,10,10aS-tetrahydro-1-hydroxy-6,6-dimethyl-
6H-dibenzo[b,d]pyran-9-methanol (HU-211), and (4-methoxyphenyl)(1-pentyl-
1H-indol-3-yl)methanone (RCS-4).  All of these compounds were purchased from 
Cayman Chemical.  The structures of these cannabinoids are referenced in Figure 
5. 
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a)                                                                  b) 
 
 
 
 
c)                      d) 
Figure 5. Structures of synthetic cannabinoids investigated: a) AM-2201, b) JWH-015, c) HU-211, 
and RCS-4 respectively. 
 
2. Substrates 
 Because synthetic cannabinoids are used to spike various plant materials, 
the substrates used for these experiments were chosen liberally.  As the results 
from the experiments are exclusively focused on the analysis of synthetic 
cannabinoids, neither the type nor amount of substrate used was optimized.  The 
substrates used were instead chosen based on the ingredients or components that 
may be found in some herbal products on the market.  One of the more popular 
synthetic cannabinoid products, “Spice,” has been reported to contain Scutellaria 
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nana, a member of the Lamiaceae plant family.  Two substrates used for analysis 
were therefore common members of the Lamiaceae family: mint and rosemary.40  
Additionally, rolling paper and tobacco were selected as substrates that were not 
botanical members of the Lamiaceae plant family.  As a result of using different 
substrates, the number of components that potentially interfere with the 
detection of target cannabinoids also varies; a more detailed evaluation is needed 
regarding the potential effects of substrate properties on cannabinoid detection.  
 Tobacco was purchased from a local merchant located in Boston, 
Massachusetts, and was the “Smoker’s Delight,” brand.  The paper that was used 
was Bambu brand rolling paper and purchased from the same local merchant 
located in Boston, Massachusetts as the tobacco samples.  Both mint and 
rosemary were packaged by McCormick (Gourmet Collection), and were 
purchased from Shaw’s Supermarket. 
3. GC/MS Conditions 
 The primary method of analysis was gas chromatography/mass 
spectrometry (GC/MS) analysis.    The instrumentation consisted of an Agilent 
Technologies 7890A gas chromatography (GC) system with a DB-5MS capillary 
column (30m x 0.25mm x 0.25m) in tandem with an Agilent Technologies 5975C 
MS.  All spectra were analyzed using AgilentTM ChemStation software. 
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III. Experimental Design 
1. Optimization Studies 
1.1 Optimizing a Burning Procedure for Synthetic Cannabinoid Analysis 
 At the time of these experiments, published procedures for the burning of 
synthetic cannabinoids, or of any of the products containing synthetic 
cannabinoids, were not discovered.  Therefore, the burning procedures used for 
the interests of these experiments were developed as part of the research 
conducted.  A proof of concept study was conducted in order to establish a 
methodology that provides an adequate burning technique.  
 For the proof of concept study, two readily available and inexpensive 
compounds were used: caffeine and procaine.  These compounds are not 
structurally similar to the cannabinoids that were examined, so the results 
obtained from these experiments were only used as confirmation that the 
burning procedure was one that would allow detection of the caffeine and 
procaine, with little risk for loss.  By extension, therefore, it was postulated that 
the burning procedure established in these studies could be used for the burning 
of the synthetic cannabinoid samples.  The chemical structures of these 
compounds are shown in Figure 6. 
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    a)                                                                               b) 
Figure 6. Structures of a) caffeine and b) procaine. 
Instead of applying direct flame to the compounds of interest, they were exposed 
to heat after they were transferred to a crucible.  Because heat is a crucial aspect 
of fire, this is one factor that can potentially affect the detection of AM-2201.  
Approximately 2mg of caffeine and procaine were measured in Eppendorf tubes 
and dissolved in 1mL of methanol.  These solutions were transferred to four, 
clean, dry, porcelain crucibles, and then evaporated to dryness at room 
temperature.  A Bunsen burner flame was applied to two crucibles for 2 minutes, 
which were then allowed to cool.  Methanol was then used to transfer all 
samples, whether unburned or burned, to clean vials.  All of the samples were 
analyzed using a designed GC/MS method known as the “BAS.m” method.  The 
parameters of this method are outlined in Table 1.   
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Table 1. Parameters of BAS.m Method 
Initial Temperature 50oC 
Ramp rate 30oC/minute 
Final hold temperature 280oC 
Final hold time 4 minutes 
Total experimental run time 12.3 minutes 
 
1.2. GC/MS Method Optimization 
 While the BAS.m method was used for the proof of concept study, the 
method parameters were not ideal for the analysis of synthetic cannabinoids.  
Specifically, the final temperature of the method was lower than published 
temperatures for GC/MS methods used to analyze synthetic cannabinoids, and 
the retention time for synthetic cannabinoids was found to generally be higher 
than the slow ramp rate warranted.  Therefore, optimization was a prudent and 
necessary aspect of the preliminary studies. 
The method that was designed for the optimized detection of AM-2201, 
AM2201SIMHM, was adapted from Agilent Technologies.  The parameters of 
this modified method are summarized in Table 2. 
Table 2. Parameters of AM2201SIMHM Method 
Initial Temperature 100oC 
Ramp rate 50oC/minute 
Final hold temperature 300oC 
Final hold time 8 minutes 
Total experimental run time 13 minutes 
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1.2.1. Selective Ion Monitoring (SIM) Methodology 
 The final GC/MS method used, AM2201SIMHM, was also programmed to 
collect selective ion monitoring (SIM) data.  Most GC/MS analyses are performed 
using scan methods, where the instrument is programmed to look for every ion 
within a specific mass range.  The resulting mass spectra are commonly used to 
compile databases for identification of unknown compounds.  Spectra from the 
Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) mass 
spectral library for the compounds analyzed are shown in Figure 7.  
 
 
 
 
 
 
 
 
 
 
Figure 7. Mass spectra of AM-2201 (a), JWH-015 (b), HU-211 (c), and RCS-4 (d) from the 
SWGDRUG database43 
a) b) 
c) d) 
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Methods can also be programmed, however, to collect SIM data, where 
fragment ions of only one or two m/z ratios are selected.  Although SIM methods 
can be less accurate than scan methods, due to the identification of unknown 
compounds based on one ion rather than several, they are advantageous due to 
the increased sensitivity.  The detection limit is generally lower using a SIM 
method because instead of detecting a range of fragment ions, an exclusive 
fragment ion is targeted and all detection capability is focused on this selected 
fragment, despite the concentration of the analyte remaining constant between 
methods.42  The use of SIM methods in forensic analysis can be beneficial due to 
the increased sensitivity afforded in comparison to scan methods.  SIM methods 
are ideal when analyzing samples that contain sources of possible contamination, 
because known fragment ions are selected, increasing the possibility of detecting 
the target analyte.  Utilizing a SIM method also allows detection of a target 
analyte if it is at a relatively lower concentration than other unknowns within the 
sample.  SIM is not without disadvantages, however.  If fewer ions are targeted, 
the identity of the compound becomes more dependent on the retention time 
observed from the gas chromatogram.  Hence while analytes can be more easily 
detected within a mixture using SIM methods, other constituents within a 
mixture that possess a similar fragment ion as the one attributed to the target 
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analyte could therefore contribute to the target analyte peak area if the gas 
chromatogram demonstrates peaks that are not entirely resolved.27 
The AM2201SIMHM method was programmed to select the molecular ion 
of AM-2201, 359 amu.  Additionally, the AM2201SIMHM method was used as a 
template to design SIM methods for the other synthetic cannabinoids that were 
studied.  The molecular weights of JWH-015, HU-211, and RCS-4 (327g/mol, 
386g/mol, and 321g/mol respecitively) were all used as the selected ion for the 
individually designed SIM methods.  The molecular weights were selected as the 
target ions as they are unique to each of the specific cannabinoids. 
2. AM-2201 Standard Analysis 
2.1 Unburned, “Neat” AM-2201 Standard Analysis 
 Unburned, or “neat,” samples of AM-2201 were prepared according to the 
procedure outlined in the proof of concept study.  Although not all the samples 
were burned, all samples were transferred to crucibles in order to maintain 
consistency in the preparation procedure.  This also minimized the potential 
decrease in detection that would simply be caused by the transferring process. 
A 2.8mg/mL solution of AM-2201 was prepared in an Eppendorf tube 
using methanol.  This solution was transferred into a clean, dry crucible and 
evaporated to dryness.  After evaporation, the original stock concentration was 
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re-constituted using methanol. This method was repeated a total of three times.  
Various concentrations were made from this stock solution, which included 25, 
50, 75, 100, 150, 200, and 250ug/mL.  These concentrations were all analyzed 
using the specified AM2201SIMHM GC/MS method. 
2.2. Burned AM-2201 Standard Analysis 
Due to limited studies related to the effect of burning on synthetic 
cannabinoid extraction and subsequent analysis, little is further known regarding 
a distinct difference between the chemical properties of unburned and burned 
synthetic cannabinoids.  Specifically, no published research was found regarding 
whether or not the act of burning AM-2201 will result in pyrolysis of the 
compound.  In order to determine whether AM-2201 pyrolyzes in response to 
burning, standards of AM-2201, without the presence of interfering plant 
substrates, were burned.  This examination therefore aimed to investigate the 
effect of burning on the detection of AM-2201, and subsequently whether or not 
the possible differences between results of AM-2201 analysis could be exclusively 
due to the chemical transformation of the compound rather than due to other 
variables introduced due to a matrix. 
 The procedure for these experiments was established in the proof of 
concept study, though the results from this study were not directly used to form 
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conclusions regarding the relative differences in detection due to burning.  A 
recorded mass of AM-2201 standard was measured in an Eppendorf tube, as 
with the unburned samples, and dissolved in 1mL of methanol.  An aliquot 
volume containing 250ug was then transferred to a clean, dry crucible, and 
evaporated to dryness.  This crucible was then heated using a Bunsen burner for 
two minutes and then cooled.  After the crucible was cool enough to handle, the 
burned AM-2201 was then recovered using methanol, which was washed into 
vials.  The methanol washes were then evaporated to dryness.  A volume of 1mL 
was then added to each residue, and the resulting solution was used to prepare a 
series of eight concentrations.  This method was performed three times. 
2.2.1 Burning of Smaller AM-2201 Concentrations 
 Initially, the concentrations of AM-2201 that were analyzed were the same 
as those that were prepared using the unburned samples, consisting of 25, 50, 75, 
100, 150, 200, and 250ug/mL.  These concentrations were chosen in order to 
determine any trends or differences between the peak areas of equivalent 
concentrations of unburned AM-2201 and burned AM-2201.  However, analysis 
of the burned AM-2201 samples showed no reproducibly detectable peak areas, 
as AM-2201 was not always detectable, and if a peak was present, it could not be 
integrated properly.   
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 The final solutions of burned AM-2201 were prepared as described above.  
The concentrations of burned samples of AM-2201 that were analyzed were 500, 
750, 1000, 1250, 1500, 2000, 3000, and 5000ug/mL.  As with the unburned AM-
2201 samples, these solutions were prepared, and analyzed, in triplicate using 
the “AM2201SIMHM” GC/MS method. 
3. Analysis of AM-2201-Spiked Substrates 
The substrates that were utilized as matrices, and thus hypothetical 
models of similar herbal products that contain synthetic cannabinoids included 
tobacco, paper, mint, and rosemary.  Before AM-2201 was added to the 
individual substrates, extracts of both unburned and burned substrates were 
analyzed separately to compile a collection of GC/MS spectra to which the 
spectra obtained from analyzing the spiked plant material could be compared. 
 For the analysis of the substrate extracts, approximately 300mg of each 
substrate was measured and placed in one of two clean, dry crucibles.  One 
sample was heated using a Bunsen burner for 2 minutes, or until the sample 
ignited.  If ignition occurred, the sample was allowed to burn until the flame 
extinguished.  After the crucible cooled, methanol was then added to both the 
burned and unburned substrates to immerse the sample, and was allowed to 
extract for 5 minutes.  This extract was then transferred to vials, and left to 
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evaporate to dryness.  A volume of 0.5mL of methanol was then added to the 
dried residues, which were subsequently analyzed. 
For the analysis of the spiked samples, approximately 300mg of each 
substrate was placed in separate crucibles as described above, and a solution of 
5000ug/mL AM2201 was added to each crucible containing the substrate.  These 
procedures were also performed in triplicate, and all extracts were analyzed 
using the “AM2201SIMHM” method. 
4. Analysis of AM-2201 Mixtures with Other Synthetic Cannabinoids 
 A key variable to consider for forensic analysis of synthetic cannabinoid 
products, in addition to possible interfering effects of components within a 
matrix, is the relative detection of one synthetic cannabinoid in the presence of 
others.  Many herbal products are sold, and could potentially be submitted to 
laboratories for analysis, consisting of several cannabinoids.  Other synthetic 
cannabinoids, therefore, were combined together in solution in order to 
determine whether or not the presence of other cannabinoids influence the 
detection of a targeted cannabinoid. 
 Stock solutions of AM-2201, JWH-015, HU-211, and RCS-4 were prepared 
in methanol.  Specific volumes of each of these cannabinoids were combined in 
order to give 1:1:1:1 dilutions of each cannabinoid (each measuring 250ug/mL) in 
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a total solution of 0.2mL of methanol.  This solution was then analyzed using the 
“AM2201SIMHM” GC/MS method, and the areas of each peak observed were 
recorded.  This procedure was further expanded to include 1:2:2:2 (125ug/mL 
AM-2201, 250ug/mL JWH-015, HU-211, and RCS-4 respectively) solutions, and 
2:1:1:1 (250ug/mL AM-2201, 125ug/mL JWH-015, HU-211, and RCS-4 
respectively) solutions.  These samples were also prepared in triplicate.  
5. Analysis of Substrates Spiked with Various Synthetic Cannabinoids 
 Finally, the synthetic cannabinoid mixtures containing all of the 
investigated cannabinoids were used to spike substrates in order to evaluate the 
effect of both the presence of substrates and of other synthetic cannabinoids on 
the detection of each cannabinoid present in the matrix.  The prepared 1:1:1:1 
mixtures of synthetic cannabinoids were used to spike the same substrates as 
previously described: tobacco, paper, mint, and rosemary. 
 
IV. Results and Discussion 
1. Unburned “Neat” AM-2201 Analysis 
 The relationship between the peak areas of unburned AM-2201 standards 
with concentration is depicted in Figure 8. 
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Figure 8. Relationship between concentration of unburned AM-2201 and the peak area 
represented by a 6-point calibration curve.  The inset shows the lowest concentrations plotted 
separately, with an individual R2 value. 
 
From these data, the peak area of AM-2201 appears to have a direct relationship 
with concentration if the 25ug/mL and 75ug/mL data is eliminated as outliers.   
This suggests that the relationship may not be as linear in a more narrow range, 
which is substantiated by the inset in Figure 8, where the R2 value decreases.  
However, there is not a significant deviation in linearity at the three lowest 
R² = 0.9872 
430000
1430000
45 65 85
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points; therefore, the linearity is shown to be maintained at the lower 
concentrations, and within this narrower range. It is likely, however, that traces 
of AM-2201 remained on the crucibles from which the AM-2201 was transferred, 
which would become a more significant source of error at lower concentrations 
than higher ones.  This potentially caused more error to be accumulated due to 
the number of steps used in the sample preparations.  The sample was 
transferred several times; therefore, it is possible that some sample remained 
after each step of the procedure, thus providing a possible source of significant 
experimental error.   
 An additional source of error includes the fact that AM-2201 was not 
derivatized prior to GC/MS analysis.  While sources of experimental error 
contributed to the high standard deviations within any one concentration, the 
absence of derivatization of a polar compound can decrease the detection 
capabilities of GC/MS.   
2. Burned AM-2201 Analysis 
 The relationship between peak area and concentration of burned AM-2201 
standards is depicted in Figure 9. 
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Figure 9. Relationship between concentration of burned AM-2201 and the peak area represented 
by a 6-point calibration curve.  The inset shows the lowest concentrations plotted separately, with 
an individual R2 value. 
 
As observed with unburned AM-2201, the peak area for AM-2201 
observed in the SIM data increases with concentration, suggesting that the 
dependent relationship is maintained despite the burning of the sample.  
Interestingly, the percent standard deviation of the triplicate measurements for 
the burned data is more pronounced in the highest concentration, which was also 
observed in the unburned data.  Sources of experimental error, such as analyte 
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loss from transferring from the crucibles may contribute to the error here, but a 
source of variability that could contribute to the high standard deviations for 
burned compounds specifically relates to the combustion of the AM-2201.  As 
previously established in the preliminary studies, higher concentrations were 
needed for the burned experiments as concentrations that were previously 
detectable as unburned compounds were not after burning.  This suggests that 
the AM-2201 degrades, sublimes, or is otherwise consumed by the process of 
combustion induced by extreme heat from the Bunsen burner.  If this rationale is 
accurate, based on the results conveyed within Figure 9, the degradation of AM-
2201 is inconsistent between the triplicate measurements at any given 
concentration for the burned samples, which consequently leads to inconsistent 
peak areas.  Further knowledge would need to be obtained, however, on the 
chemical and physical properties of this compound in order to form a definitive 
conclusion. 
As previously mentioned, the standard deviations could be high because 
the samples were not derivatized before analysis.  The mechanism and product 
of thermal degradation for AM-2201 is unknown; thus derivatization of a burned 
sample of AM-2201 could vary slightly from derivatization of an unburned 
sample.  Further research and information regarding the degradation of AM-
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2201 would need to be obtained to fully understand the benefits of derivatizing 
burned synthetic cannabinoids. 
3. Effect of Burning on AM-2201 Peak Area 
 The correlation between the peak area and the concentration of AM-2201 
can be represented by the equations of the linear trendlines.   
The equations of the line for the unburned (U) and burned (B) standards of AM-
2201 are shown below. 
  y(U) = 35,811x(U) - 2E+06 
  y(B) = 4715.1x(B) - 2E+06 
These equations can further be combined to produce the following expression: 
  y(U) – y(B) = 35,811x(U) – 4715.1x(B) 
  y(U) – y(B) = 35,811 (x(U) – 0.132x(B)) 
Consequently, if the AM-2201 concentrations are equivalent, the correlation 
between the difference of peak areas and concentration of burned and unburned 
AM-2201 is: 
  y(U-B) = 35,811 (1 – 0.132(x(U, B))) 
  y(U-B) = 35,811 (0.869(x(U, B))) 
  y(U-B) = 31,096(x(U, B)) ± 29,894 
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Therefore, the difference in the peak area for equivalent concentrations of AM-
2201 (burned and unburned) can be approximated to be 31,096 times. 
 
Similarly, if the equations are combined, a relationship between the 
concentration of burned AM-2201 (x(B)) and unburned AM-2201 (x(U)) is 
calculated to be: 
 
  35811x(U) - 2E+06 = 4715.1x(B) - 2E+06 
    OR 
  4715.1x(B) = 35811x(U)  
This simplifies to: 
  x(B) = 7.59x(U) ± 11.01 
where the peak area terms for burned and unburned standards are considered 
equal.  This equation mathematically demonstrates that in order to achieve 
comparable peak areas, a burned sample of AM-2201 is required to be analyzed 
in a solution that is at least 8 times more concentrated than the respective 
unburned solution.  This relationship further suggests that while the limits of 
detection were not specifically identified, the limit of detection of burned AM-
2201 would be expected to be significantly higher than that of unburned AM-
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2201.  A possible explanation is that the majority of AM-2201 in a given sample is 
degraded by the extreme heat applied to the sample.   
4. AM-2201 Unburned Matrix Samples 
The peak areas obtained from spiked substrates were divided by the peak 
areas obtained from analyzing pure solutions of AM-2201 in order to determine a 
percentage between the two values, therefore obtaining normalized values that 
are suitable for comparison between the substrates.  The lower percentages 
represent the greatest difference between the peak area observed from analyzing 
standard AM-2201 to analyzing AM-2201 when present in a matrix.  These 
results are summarized in Figure 10. 
Figure 10. Proportion of AM-2201 observed from 250ug/mL present in a matrix compared to 
250ug/mL neat solution.  These experiments were performed in triplicate. 
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The presence of a substrate appears to cause a variation between the peak 
areas of AM-2201.  This could be due to various factors, such as differing 
adsorption affinities between the substrate and the AM-2201.  If a given substrate 
demonstrates a higher adsorption affinity for AM-2201 compared to another, the 
recoverability of the AM-2201 is then diminished.  Upon comparing the peak 
area percentages of all the substrates, paper was found to be the substrate that 
yielded the lowest percent peak area.  Paper, as a non-botanical substrate, would 
not have the same adsorption affinities, or other physical properties, as the other 
substrates that are unprocessed plant material.  The decrease in percent peak 
area is therefore more likely due to differences in AM-2201 affinity for the 
botanical substrates.  If this hypothesis were valid, there would be evidence of 
such differences found in the peak areas of AM-2201 obtained from spiked 
substrates and those obtained from pure unburned AM-2201. 
The peak areas obtained from the analysis of paper extracts were also 
found to demonstrate the largest standard deviation.  These deviations are likely 
due to the lack of reproducibility that was caused by significant analysis 
considerations and variations that were encountered during the sample 
preparation.  AM-2201 that was used to spike tobacco was found to have the 
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highest percentage of AM-2201 peak area, which suggests that most of the AM-
2201 was successfully extracted from the substrate, possibly due to the tobacco 
demonstrating a lower affinity for AM-2201. 
5. AM-2201 Burned Spiked Matrix Samples 
 An AM-2201 concentration of 250ug/mL was previously determined to 
not be detectable after burning; therefore 500ug/mL solutions were used to spike 
substrates that were then burned.  Despite an increase in concentration, however, 
AM-2201 could not be detected in extracts from the burned spiked samples. 
 As observed from the analysis of unburned substrates that had been 
spiked with AM-2201 (Figure 9), varying degrees of affinity for AM-2201 appear 
to be based on the substrate.  In order to investigate whether or not burned 
substrates also have different degrees of AM-2201 affinity, a supplemental series 
of experiments was designed and performed.  All substrates were burned, and 
then subsequently spiked with a 500ug/mL solution of AM-2201, extracted, and 
then analyzed by GC/MS.   
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           c) 
Figure 11. AM-2201 SIM data for a) unburned, b) burned (after spiking), and c) burned (before 
spiking) tobacco. 
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The results from analyzing extracts that were spiked after burning were used to 
demonstrate that the loss of analyte observed is due to the burning and 
combustion process alone, and not due to a greater AM-2201 affinity for burned 
substrates.   
 AM-2201 was successfully extracted from all burned substrates, which 
were subsequently spiked, and analyzed.  This infers, therefore, that the 
significant decrease in peak area for AM-2201 in a burned spiked substrate is 
more likely due to the burn procedure rather than variables related to the 
substrates.  SIM data for all tobacco extracts of AM-2201 (from unburned 
tobacco, burned tobacco, and tobacco that was burned before spiking the 
substrate) are exhibited in Figure 11.  Results from all matrices demonstrated 
similar results; most importantly, no results from extraction of other matrices 
demonstrated evidence that the presence of burned matrices significantly 
affected the analysis of AM-2201. 
There appears to be a decrease in peak area in Figure 11, part c), which 
could be due to interactions between AM-2201 and the burned matrix, but the 
extreme decrease in peak area observed in Figure 11, part b) is most likely due to 
effects ensued from burning.  A concentration that is known to be detectable 
when AM-2201 is burned (500ug/mL) would no longer be detectable if burned 
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with a substrate because the substrate provides a fuel for the burning, which 
causes the heat to increase.  The increased heat then causes more AM-2201 to be 
degraded or sublimed, compared to what is observed from heating a pure 
compound.  When pure AM-2201 was heated, smoke was observed, indicating 
combustion, but when the substrates were heated, ignition occurred.  This 
observation further adds to the theory that faster, or more intense, combustion 
may cause AM-2201, and by extension other cannabinoids, to be more difficult to 
detect. 
6. Cannabinoid Mixture Analysis 
 It is unlikely that an herbal product containing synthetic cannabinoids 
that is submitted for analysis would contain only one cannabinoid, as products 
that have been analyzed all contain several cannabinoids.17  It is therefore useful 
to investigate the possible effect of the presence of other synthetic cannabinoids 
as another variable.  
Synthetic cannabinoids are frequently found in herbal products at varying 
concentrations.21  As previously discussed, the relationship between 
concentration and peak area is direct and linear over a moderate range of 
concentrations.  Mixtures of AM-2201, JWH-015, HU-211, and RCS-4 were 
combined together to determine whether or not this linear relationship would be 
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maintained for any specific cannabinoid in the presence of other cannabinoids.  
AM-2201, JWH-015, HU-211, and RCS-4 were combined together to make a 
1:1:1:1 mixture of each cannabinoid at a concentration of 250ug/mL in 0.2mL of 
methanol, and was subsequently analyzed.  The concentration of each 
cannabinoid was then doubled to 2:1:1:1 (in relation to JWH-015), and each 
solution was analyzed using individual SIM methods for every cannabinoid.  
The results from these tests are shown in Figure 12.  Peak areas of HU-211 are 
featured again in Figure 13 in order to observe the results clearly. 
Figure 12. Peak areas of various synthetic cannabinoids in solution, varying from 250ug/mL to 
500ug/mL. 
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Figure 13. Peak areas of HU-211 in solution with other synthetic cannabinoids (not shown). 
Two important aspects can be derived from these data.  First, there is a wide 
range of peak area variation among the different synthetic cannabinoids, despite 
being at equivalent concentrations.  For example, HU-211 is the cannabinoid that 
was the most difficult to detect, as the associated peak area was vastly smaller 
than those of the other cannabinoids.  Second, the doubled concentration 
increased the peak area of the respective cannabinoid in all cases, but the degree 
to which doubling the concentration affected the peak areas of each cannabinoid 
relative to one another did not remain consistent.  For example, AM-2201 
exhibited a peak area that was smaller than either JWH-015 or RCS-4, whether it 
was twice the concentration or not.  The peak area of RCS-4, however, surpassed 
that of JWH-015 when the concentration was doubled, having been lower in all 
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the other solutions.  One important consideration is that although these 
concentrations are equivalent, the concentrations are based on mass; therefore 
the absolute number of molecules per unit of volume is not equivalent between 
cannabinoids.  The differences in the number of molecules between the 
cannabinoids in a GC injection of a given volume could then have potentially 
contributed to the differences in peak area response.   However, as the 
cannabinoids only differ slightly in molar mass, it is more likely that the 
differences in response are due to differences in physical properties, which 
include differences in volatility, thermal stability, and ionization efficiency.  All 
of these physical properties would be expected to be analyte-dependent, and 
therefore, the differences observed are best explained by a thorough 
understanding of the chemical and physical properties of these compounds.   
 As increasing the concentration results in varying effects among different 
cannabinoids, varying the substrate onto which a cannabinoid mixture is spiked 
could also demonstrate differing peak areas.  A 1:1:1:1 solution of the 
cannabinoids was used to spike the following substrates: tobacco, paper, mint, 
and rosemary, to observe the different peak areas obtained from each 
cannabinoid when applied to a different matrix.  The sum of all peak areas from 
all cannabinoids from each substrate was calculated, and the individual peak 
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areas from each cannabinoid were divided by this total to give a percentage of 
the peak area for each cannabinoid.  These percentages were then compared to 
those from a 1:1:1:1 neat solution of a cannabinoid mixture.  These results are 
shown in Figure 14. 
 
Figure 14. Proportions of peak area from each cannabinoid in a 1:1:1:1 solution, and in various 
spiked substrates.  These experiments were performed in triplicate. 
 
 In general, the peak area percentages of each synthetic cannabinoid 
remain consistent with each substrate.  Interestingly, however, HU-211 appears 
to be more detectable when extracted from a spiked substrate, as shown from the 
increased peak area.  Differences in HU-211 affinity could have contributed to 
the lower peak areas of HU-211 observed from the analysis of cannabinoid 
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mixtures compared to peak areas observed from the analysis of the substrate 
extracts.  However, the drastic differences observed between the peak areas of 
HU-211 and the other cannabinoids are attributed to a lower instrument 
detection sensitivity. 
 Another relevant trend is that associated with the standard deviation of 
the peak areas observed from the error.  Although the standard deviations of the 
peak areas remain relatively small for cannabinoid solutions and tobacco 
extracts, those for the other substrates appear to be significantly larger.  This 
could be due to the different affinities demonstrated by the individual substrates.  
IV. Conclusions 
 There were three main variables that were explored in these studies that 
were thought to possibly affect the detection and analysis of synthetic 
cannabinoids: the effects of burning, the presence of a matrix, and the presence of 
other synthetic cannabinoids.  All variables represent possible sources of 
difficulty when analyzing herbal products that contain synthetic cannabinoids.  
Upon consideration of all of the results obtained from these experiments, all 
three variables appear to affect the facility of cannabinoid analysis.  Burning 
cannabinoids resulted in a decrease in peak area, which was likely due to 
degradation of the analyte from the applied heat.  The results from analyzing 
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synthetic cannabinoids combined with substrates demonstrated that there was 
also an observable decrease in peak area when synthetic cannabinoids were 
introduced to substrates.  Additionally, there was an observed trend of decreased 
peak areas between individual substrates.  These decreased peak areas are most 
likely due to varying affinities between different cannabinoids and respective 
substrates.  The presence of other synthetic cannabinoids appears to also affect 
the analysis of target analytes, particularly when analysis is done using SIM 
methods.  Differences in physical properties, including volatility, thermal 
stability, and ionization efficiency, between individual synthetic cannabinoids 
possibly contribute to varying peak areas of each cannabinoid analyzed.  It is 
recommended, therefore, that further research into all of these aspects should be 
continued. 
V. Discussion and Future Directions 
 The purpose of these studies was to explore the potential difficulties of 
synthetic cannabinoid extraction and analysis by GC/MS that arise from 
cannabinoids being present in a matrix consistent with materials that would be 
smoked.  Although the results suggested that the burning of synthetic 
cannabinoids and the presence of a substrate affects the detection of synthetic 
48 
 
cannabinoids, there are many areas that could be explored to further understand 
these effects. 
This thesis focused on four cannabinoids and four types of substrates.  
Clearly, conclusions regarding any observed effects would have more 
significance if a wider array of synthetic cannabinoids were studied, and if more 
substrates were used.  Furthermore, if the more popular synthetic cannabinoids, 
such as the cannabinoids that were emergency-scheduled, or if the commercial 
products containing the scheduled synthetic cannabinoids could be studied, the 
data could be immensely useful. 
The effect of burning on the detection of synthetic cannabinoids was 
studied, but there are many opportunities to continue the work performed.  AM-
2201 was detectable when extracted from a substrate following burning, so it is 
therefore likely that other synthetic cannabinoids would be detectable following 
the same procedure.  However, a more detailed investigation of this area could 
be pursued, where higher concentrations of various synthetic cannabinoids 
(separate or in a mixture) are burned in attempt to determine a limit of detection 
(LOD) for specific synthetic cannabinoids after burning.  Furthermore, the 
decrease in detection after burning, and how it changes with different substrates 
that are spiked could possibly be explored. 
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The substrates were chosen based on botanical similarity to some 
ingredients found in commercial products that contain synthetic cannabinoids.  
However, characteristics of materials found in the illicit products containing 
scheduled cannabinoids could be significantly different than those of the 
substrates that were analyzed.  It would be beneficial, therefore, to study herbal 
incense products that are sold on the market.  Similarly, there could be benefit to 
studying more complex mixtures of synthetic cannabinoids, where both the type 
and amount of substrate is varied in addition to the type and number of other 
synthetic cannabinoids present in the mixture. 
 Another aspect of analysis that could be further investigated is the 
possible benefit of derivatizing AM-2201 or other synthetic cannabinoids before 
conducting analysis using GC/MS.  Synthetic cannabinoids contain polar 
functional groups, which decrease the efficacy of GC/MS as an analytical 
method.  Agilent Technologies published several collections of spectra and 
methods that featured synthetic cannabinoids in solution, which were 
derivatized prior to analysis.  Further studies should consider the benefits of 
derivatization, as the high standard deviations encountered in the data may have 
been avoided or decreased if the cannabinoids were derivatized before analysis.  
In addition to polar functional groups, the possibility also exists that synthetic 
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cannabinoids lack sufficient volatility to be analyzed by GC/MS.  During initial 
stages of this study, the relationship observed in increasing peak areas of 
unburned and burned AM-2201 due to concentration appeared polynomial in 
nature when smaller concentrations ranges (initially from 10ug/mL of AM-2201 
to 100ug/mL) were used.  This trend could be due to the presence of active sites 
in the inlet of the GC/MS with high affinities for AM-2201, which would cause 
analytes to become trapped in the liner instead of successfully adsorbing to the 
column, which is necessary for analysis.  However, a more likely explanation  for 
the trend is that AM-2201 and other synthetic cannabinoids lack sufficient 
volatility for GC/MS analysis.  If the cannabinoids are not adequately volatized, 
some of the analyte may not be detectable, and at lower concentrations, the 
percentage of analyte lost would be higher.  Therefore the option of 
derivatization for the purposes of addressing polar functional groups and 
increasing volatility of the compounds, or other preparation procedures that 
could potentially improve the linearity of this trend, could be another area for 
further study.  More specifically, derivatization would be highly beneficial for 
quantitation of synthetic cannabinoids in a given sample, or for other 
experiments where reproducibility is important. 
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 A problematic area of these studies was the standard deviation of the peak 
areas.  The standard deviation was high between triplicates (or showed 
significant deviation), which subsequently resulted in the high errors.  Studies 
focused on optimizing experimental parameters to minimize these sources of 
high variability (which could possibly include derivatization procedures) could 
also greatly contribute to further development in this area. 
 As previously mentioned, the burn procedure was developed and utilized 
based on rational design and experimentation.  Optimization studies of burning 
procedures would undoubtedly contribute to developing burning methods with 
fewer sources for error in cannabinoid analysis.  Further investigation into 
variables that affect the manner of burning could also expand the research 
conducted to include how the detection of synthetic cannabinoids is affected by 
specific manners of burning. .  Such variables that could be studied include, but 
are not limited to, temperature of the flame used, duration of time that the 
sample is exposed to heat or flame, and direct exposure of the sample to a flame, 
rather than applying heat. 
 The instrumental methodology used to analyze synthetic cannabinoids 
could also be a source of future developments.  GC/MS was the only analytical 
method used for these studies, but other instrumentation could possibly be 
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useful for these analyses, such as FT-IR, or LC/MS, for example.  LC/MS could be 
a preferred instrumental technique as previous research suggests that it has been 
successfully used to analyze components in commercially available herbal 
products containing synthetic cannabinoids.21 
Submitted illicit substance exhibits commonly include burned products; 
therefore, the analysis of burned samples that contain synthetic cannabinoids is a 
relevant area of forensic research.    Variables such as components present in 
burned plant material instead of unburned material, and the heat from the 
combustion of the plant material, can potentially have a significant effect on the 
detection of illicit substances within the samples.  Unlike other illicit substances 
analyzed from plant material, however, synthetic cannabinoids are not naturally 
present in the product in which they are found.  There are potentially many other 
factors, currently unknown, that could interfere with the analysis of cannabinoid-
containing exhibits, all of which could be further pursued and studied in order to 
obtain a more detailed understanding of the effects on analysis of synthetic 
cannabinoids.  Furthermore, as these products increase in popularity, and as 
more cannabinoids become commercially available, the high potential for 
botanical and chemical variability with the products will likely continue to fuel 
the research surrounding additional aspects of these compounds. 
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